Skip to main content
OpenTrials
Completed

NCT Number: NCT04335877

Effect of Prompting the Supply of Zinc/LO-ORS Co-packs in the Private Sector Plus BCI on Childhood Diarrhea Treatment

This study assesses whether prompting the supply of zinc and LO-ORS co-packs in the private sector coupled with behavior change communication (BCC) has an effect on the treatment of uncomplicated childhood diarrhea. In addition the study will evaluate the acceptability, adoption, feasibility and coverage of the intervention model. One group of children and caregivers will receive the current standard of care and will be exposed to standard BCC and the second group will be exposed to the private sector component and to a modified BCC.

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 month–60 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nutrition International - Kenya

Nairobi, Kenya

About this study

Diarrhoea accounts for 7% of all under-five deaths in Kenya. Recent experiences in other countries show that the private health sector can be successfully harnessed to improve diarrhoea treatment coverage.

This study assesses the effect of prompting the supply of zinc and low-osmolarity oral rehydration salts (LO-ORS) co-packs in the private sector coupled with increasing the demand for co-packs among caregivers on: 1) the treatment of uncomplicated childhood diarrhoea, 2) care-seeking in the private sector, and 3) availability of co-packs in the private sector.

The target population will be children under five years of age and their caregivers in Vihiga County. The study will use a effectiveness-implementation hybrid design with two arms: 1) children and caregivers from areas that receive the current standard of care and will be exposed to standard BCC and 2) children and caregivers from areas where the private sector component will be implemented and that will be exposed to a modified BCC. Two of the five existing sub-counties in Vihiga will be selected by convenience to be assigned to one of the two study arms. The selection will take into account geographical distance between the two sub-counties (i.e. maximizing the distance between the two counties to minimize cross-pollination between the two study groups), rural vs urban population, and number of operational community units and CHV in each sub-county. All private sector retailers within each sub-county will be identified with assistance from wholesalers. Retailers will be invited to participate in the study via sensitization meetings.

Baseline and endline assessments will be conducted at the household level to collect information on care-seeking practices, availability of the co-pack in the household, treatment of diarrhoea, and whether caregivers received information from shopkeepers on using the co-pack. Monitoring of process indicators will be conducted throughout the intervention period. The monitoring process will also be used to evaluate the adoption and feasibility of the implementation model. In addition, the endline survey will be used to evaluate the acceptability, adoption, and coverage of the implementation model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All children under 5 years of age who live in the selected areas to be included in the study are eligible to participate. All children in area selected for the intervention will be exposed to the private sector component and the modified BCC.
  • In addition, all private sites (shops, kiosks, chemists) in the intervention area will be eligible to participate in the study.

Exclusion criteria

  • None

Treatment and study plan

Private sector component + modified BCC

Other

Intervention group will be exposed to the private sector component + modified BCC and will receive current standard care

Primary outcomes

  1. Treatment of uncomplicated diarrhea

    Time frame: 12 months

    change in % of caregivers who use zinc and LO-ORS co-pack to treat uncomplicated childhood diarrhea at 12 months

  2. Care-seeking in the private sector

    Time frame: 12 months

    Change in % of caregivers seek care for uncomplicated childhood diarrhea in the private sector at 12 months

  3. Availability of zinc and LO-ORS co-pack in the private sector

    Time frame: 12 months

    Change in % of private retailers who have stock of zinc and LO-ORS co-pack at time of visit at 12 months

  4. Acceptability of private sector

    Time frame: 1 month

    % private retailers who express intention to stock co-packs after sensitization and training.

  5. Acceptability of caregivers

    Time frame: 12 months

    % caregivers who indicate preferred treatment for uncomplicated childhood diarrhea is co-pack.at 12 months

  6. Adoption by private sector at month 1

    Time frame: 1 month

    % private retailers who stock co-pack after 1 month

  7. Adoption by private sector at month 2

    Time frame: 2 months

    % private retailers who stock co-pack after 2 months

  8. Adoption by private sector at month 3

    Time frame: 3 months

    % private retailers who stock co-pack after 3 months

  9. Adoption by private sector at month 4

    Time frame: 4 months

    % private retailers who stock co-pack after 4 months

  10. Adoption by private sector at month 5

    Time frame: 5 months

    % private retailers who stock co-pack after 5 months

  11. Adoption by private sector at month 6

    Time frame: 6 months

    % private retailers who stock co-pack after 6 months

  12. Adoption by private sector at month 7

    Time frame: 7 months

    % private retailers who stock co-pack after 7 months

  13. Adoption by private sector at month 8

    Time frame: 8 months

    % private retailers who stock co-pack after 8 months

  14. Adoption by private sector at month 9

    Time frame: 9 months

    % private retailers who stock co-pack after 9 months

  15. Adoption by private sector at month 10

    Time frame: 10 months

    % private retailers who stock co-pack after 10 months

  16. Adoption by private sector at month 11

    Time frame: 11 months

    % private retailers who stock co-pack after 11 months

  17. Adoption by private sector at month 12

    Time frame: 12 months

    % private retailers who stock co-pack after 12 months

  18. Adoption by caregivers

    Time frame: 12 months

    % caregivers who indicate having co-pack in house

  19. Feasibility of intervention at month 1

    Time frame: 1 month

    % private retailers who indicate that they can purchase/procure co-packs with ease after 1 month

  20. Feasibility of intervention at month 2

    Time frame: 2 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 2 months

  21. Feasibility of intervention at month 3

    Time frame: 3 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 3 months

  22. Feasibility of intervention at month 4

    Time frame: 4 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 4 months

  23. Feasibility of intervention at month 5

    Time frame: 5 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 5 months

  24. Feasibility of intervention at month 6

    Time frame: 6 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 6 months

  25. Feasibility of intervention at month 7

    Time frame: 7 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 7 months

  26. Feasibility of intervention at month 8

    Time frame: 8 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 8 months

  27. Feasibility of intervention at month 9

    Time frame: 9 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 9 months

  28. Feasibility of intervention at month 10

    Time frame: 10 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 10 months

  29. Feasibility of intervention at month 11

    Time frame: 11 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 11 months

  30. Feasibility of intervention at month 12

    Time frame: 12 months

    % private retailers who indicate that they can purchase/procure co-packs with ease after 12 months

Secondary outcomes

  1. Care-seeking to all sources

    Time frame: 12 months

    Change in % of caregivers who seek care for childhood diarrhea outside the home at month 12

  2. Prompt treatment of uncomplicated childhood diarrhoea with zinc and LO-ORS co-pack

    Time frame: 12 months

    Change in % of caregivers who use zinc and LO-ORS co-pack to treat uncomplicated childhood diarrhea within 24-h of the onset of the episode of diarrhea at 12 months

  3. Caregivers receive information from private retailers

    Time frame: 12 months

    Change in % caregivers who indicate received information from private retailers about zinc and LO-ORS to treat uncomplicated childhood diarrhea at 12 months

Sponsors and collaborators

Lead sponsor

Nutrition International

Other

Registry information

Official study title

Effectiveness-Implementation Research to Assess the Effect of Prompting the Supply of Zinc/LO-ORS Co-packs Through the Private Sector Coupled With Behavior Change Intervention on the Treatment of Uncomplicated Childhood Diarrhoea in Kenya

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Apr 6, 2020
Registry last updated
Apr 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.